© 2006 American Public Health Association DOI: 10.2105/AJPH.2004.042010
At the time of the study, Rita M. Melendez was with the HIV Center for Clinical and Behavioral Studies, Columbia University and New York State Psychiatric Institute, New York, NY. Theresa A. Exner, Anke A. Ehrhardt, Brian Dodge, and Robert H. Remien are with the HIV Center for Clinical and Behavioral Studies, Columbia University and New York State Psychiatric Institute. Mary-Jane Rotheram-Borus, Marguerita Lightfoot, and Daniel Hong are with the University of California, Los Angeles. Correspondence: Requests for reprints should be sent to Rita M. Melendez, PhD, San Francisco State University, Human Sexuality Studies and Center for Research on Gender and Sexuality, 2017 Mission St, Suite 300, San Francisco, CA 94110 (e-mail: rmelende{at}sfsu.edu).
Recent studies have reported high rates of HIV infection among male-to-female transgender persons, but little research has examined how male-to-female transgender persons manage living with HIV. We compared demographic and health characteristics of 59 male-to-female transgender persons who were HIV positive with 300 nontransgender control subjects who were HIV positive. We found several demographic differences between the groups but no significant differences in HIV-related health status. Male-to-female transgender persons were less likely than the control group to take highly active antiretroviral therapy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||